Marie-France Tschudin
Director/Board Member bei AXA
Vermögen: 5 Mio $ am 31.03.2024
Aktive Positionen von Marie-France Tschudin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AXA | Director/Board Member | 30.06.2020 | - |
Independent Dir/Board Member | 30.06.2020 | - | |
IMD Scholarship Foundation | Director/Board Member | - | - |
Karriereverlauf von Marie-France Tschudin
Ehemalige bekannte Positionen von Marie-France Tschudin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 04.04.2022 | 15.09.2023 |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | President | 01.03.2019 | 01.06.2019 |
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Corporate Officer/Principal | - | 01.01.2016 |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | President | - | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 04.04.2022 | - |
European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - | - |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Director/Board Member | - | - |
Ausbildung von Marie-France Tschudin
Georgetown University | Undergraduate Degree |
International Institute for Management Development | Masters Business Admin |
Statistik
International
Schweiz | 7 |
Frankreich | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
President | 2 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AXA | Finance |
NOVARTIS AG | Health Technology |
Private Unternehmen | 7 |
---|---|
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
IMD Scholarship Foundation | |
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
European Federation of Pharmaceutical Industries & Assoc | Commercial Services |
- Börse
- Insiders
- Marie-France Tschudin
- Erfahrung